BioSpace News Archive

AI Innovation for automated Detection and Classification of osteoporotic Fractures of the Spine in CT Scans - ImageBiopsy Lab launches IB Lab FLAMINGO

ImageBiopsy Lab, a pioneer in medical imaging, introduces IB Lab FLAMINGO at this year’s RSNA conference.

November 29, 2023
·
3 min read
Drug Development

Opsidio Announces First Patient Dosed in Phase 2a Trial of OpSCF in Moderate to Severe Atopic Dermatitis

Opsidio, LLC today announced the dosing of the first patient in the Phase 2a clinical trial of OpSCF, Opsidio’s pioneering monoclonal antibody against stem cell factor, in patients suffering from moderate to severe atopic dermatitis.

November 29, 2023
·
2 min read
Bio NC

IQVIA Digital Enablement Named PM360 Trailblazer 2023 Supplier/Vendor of the Year

IQVIA™ today announced that IQVIA Digital Enablement has been named a PM360 Trailblazer 2023 Company of the Year in the Supplier/Vendor category.

November 29, 2023
·
3 min read
Biotech Beach

Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development

Bionano Genomics, Inc. announced a publication demonstrating the use of optical genome mapping to identify structural variations introduced by CRISPR-Cas9 gene editing of CD4+ T-cells that could potentially limit the therapeutic use of such edited cells.

November 29, 2023
·
5 min read
Policy

Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)

Company’s DCA Solution Offers Robust Set of User and Medical Practitioner Features via an Android & iOS Mobile App and a Clinician Dashboard For Monitoring Patient’s Cough

November 29, 2023
·
5 min read
Business

Eagle Pharmaceuticals Announces Management Change

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced a change in management.

November 29, 2023
·
5 min read
INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium

INmune Bio, Inc. is presenting data on the use of INB03, a dominant-negative TNF inhibitor of soluble TNF (sTNF) in the treatment of high-risk MUC4 expressing HER2.

November 29, 2023
·
6 min read
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

China Pharma Holdings, Inc. announced that its Dry Eye Disease therapeutic device has passed third-party testing and is preparing to apply for market launch to the National Medical Products Administration of China.

November 29, 2023
·
3 min read
Drug Development

BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s Disease

BioVie Inc. today announced positive analysis of unblinded, topline efficacy data from its Phase 3 clinical trial (NCT04669028) of NE3107 in the treatment of mild to moderate Alzheimer’s Disease (AD).

November 29, 2023
·
14 min read
Pharm Country

Insmed To Present at the Nasdaq 49th Investor Conference

Insmed Incorporated today announced that management will present at the Nasdaq 49th Investor Conference in London on Wednesday, December 6, 2023 , at 8:30 a.m. ET / 1:30 p.m. GMT.

November 29, 2023
·
1 min read